Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016 [version 1; referees: 4 approved]

Market penetration of Xpert MTB/RIF in high tuberculosis burden countries: A trend analysis from 2014 - 2016 [version 1; referees: 4 approved]

Background: Xpert® MTB/RIF, a rapid tuberculosis (TB) molecular test, was endorsed by the World Health Organization in 2010. Since then, 34.4 million cartridges have been procured under concessional pricing. Although the roll out of this diagnostic is promising, previous studies showed low market pe...

Full description

Bibliographic Details
Main Authors: Danielle Cazabon, Tripti Pande, Sandra Kik, Wayne Van Gemert, Hojoon Sohn, Claudia Denkinger, Zhi Zhen Qin, Brenda Waning, Madhukar Pai
Format: Article
Language:English
Published: F1000 Research Ltd 2018-07-01
Series:Gates Open Research
Online Access:https://gatesopenresearch.org/articles/2-35/v1

Similar Items

Similar Items